Side effects include abdominal cramping, bloating, diarrhea, and flatulence, leading to low rates of adherence (19). Rifaximin is a nonabsorbable antibiotic that reduces the risk of recurrent hepatic encephalopathy and hospitalization from hepatic encephalopathy (29).